NIMU, NMRC sign CRADA agreement

Non-Invasive Monitoring Systems, Inc. [NIMS](OTCBB:NIMU) announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC) in Silver Springs, MD to evaluate the benefit of Exer-Rest for patients with traumatic brain injury (TBI).

“Whole Body Periodic Acceleration therapy increases endogenous nitric oxide in the circulation, a natural anti-inflammatory molecule that offers potential to help TBI patients by increasing brain blood flow, reducing inflammation and oxidative stress thereby relieving neuropsychiatric symptoms and improving vitality.”

The Exer-Rest^® is a Class I Exempt, non-invasive medical device which applies Whole Body Periodic Acceleration (WBPA) from head-to-foot to improve circulation and provide pain relief.

Military service members are being deployed to areas where they are at risk for blast exposures from improvised explosive devices (IEDs), suicide bombs, land mines, mortar rounds, rocket-propelled grenades etc. According to the United States Army, $361 million was spent on care and research for TBI in 2008 and 2009.

Dr. Marvin Sackner, NIMS founder and CEO noted "Whole Body Periodic Acceleration therapy increases endogenous nitric oxide in the circulation, a natural anti-inflammatory molecule that offers potential to help TBI patients by increasing brain blood flow, reducing inflammation and oxidative stress thereby relieving neuropsychiatric symptoms and improving vitality."

Exer-Rest is available in the United States, Canada and other major international markets. It is an FDA listed medical device intended as an aid to temporarily increase local circulation, to provide temporary relief of minor aches and pains, to reduce morning stiffness and to provide local muscle relaxation. The Exer-Rest is also approved in the United Kingdom, European Union, Health Canada and Mexico as an aid to increasing circulation and for increasing joint mobility.